Federated Hermes’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$107M Buy
1,686,494
+94,623
+6% +$5.98M 0.2% 139
2025
Q1
$84.3M Buy
1,591,871
+42,236
+3% +$2.24M 0.18% 140
2024
Q4
$86.7M Sell
1,549,635
-114,265
-7% -$6.4M 0.19% 137
2024
Q3
$87.2M Buy
1,663,900
+3,116
+0.2% +$163K 0.19% 142
2024
Q2
$68.2M Sell
1,660,784
-313
-0% -$12.9K 0.16% 171
2024
Q1
$72M Sell
1,661,097
-649,858
-28% -$28.2M 0.17% 165
2023
Q4
$106M Sell
2,310,955
-30,380
-1% -$1.4M 0.26% 89
2023
Q3
$53.7M Sell
2,341,335
-1,550,348
-40% -$35.5M 0.14% 184
2023
Q2
$64.2M Hold
3,891,683
0.16% 154
2023
Q1
$69.4M Sell
3,891,683
-2,412,799
-38% -$43M 0.17% 133
2022
Q4
$184M Sell
6,304,482
-2,384
-0% -$69.4K 0.51% 38
2022
Q3
$155M Buy
6,306,866
+1,911,266
+43% +$46.8M 0.45% 45
2022
Q2
$18.2M Sell
4,395,600
-669,513
-13% -$2.78M 0.05% 410
2022
Q1
$58.4M Buy
5,065,113
+2,261,778
+81% +$26.1M 0.13% 200
2021
Q4
$28M Sell
2,803,335
-207,718
-7% -$2.07M 0.05% 407
2021
Q3
$39.3M Sell
3,011,053
-4,158
-0.1% -$54.3K 0.07% 332
2021
Q2
$59M Sell
3,015,211
-95,642
-3% -$1.87M 0.11% 241
2021
Q1
$66.2M Buy
3,110,853
+493,253
+19% +$10.5M 0.13% 206
2020
Q4
$77.8M Buy
2,617,600
+350,000
+15% +$10.4M 0.16% 164
2020
Q3
$49.1M Buy
2,267,600
+1,529
+0.1% +$33.1K 0.12% 207
2020
Q2
$50.5M Buy
2,266,071
+171
+0% +$3.81K 0.13% 185
2020
Q1
$34.5M Buy
2,265,900
+107,881
+5% +$1.64M 0.1% 217
2019
Q4
$49.5M Buy
2,158,019
+692,619
+47% +$15.9M 0.11% 217
2019
Q3
$31.6M Buy
1,465,400
+573,200
+64% +$12.4M 0.08% 260
2019
Q2
$19.6M Hold
892,200
0.05% 357
2019
Q1
$24.5M Sell
892,200
-1,044
-0.1% -$28.6K 0.06% 301
2018
Q4
$24M Buy
893,244
+102,823
+13% +$2.76M 0.07% 295
2018
Q3
$23.1M Buy
790,421
+540,421
+216% +$15.8M 0.05% 320
2018
Q2
$7.82M Buy
250,000
+100,000
+67% +$3.13M 0.02% 548
2018
Q1
$2.99M Hold
150,000
0.01% 799
2017
Q4
$4.36M Buy
+150,000
New +$4.36M 0.01% 655